{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:12:46Z","timestamp":1760573566583,"version":"build-2065373602"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Mitotically active cellular fibroma (MACF) is a rare ovarian neoplasm characterized by mild to moderate cytological atypia and increased mitotic activity, often presenting diagnostic challenges due to its overlap with ovarian fibrosarcoma. Although MACF has low malignant potential and generally confers a favorable prognosis, accurate diagnosis is essential to avoid overtreatment and to guide appropriate management. We retrospectively analyzed a 33-year-old woman with a 5cm left ovarian mass showing abundant vascularity on ultrasonography. Pathological examination revealed a cellular fibroma with moderate atypia, a high mitotic rate (15\/10 High-Power Fields [HPF]), and a Ki-67 index of 60%, creating diagnostic ambiguity with fibrosarcoma. Following multidisciplinary review and adherence to World Health Organization (WHO) criteria, a diagnosis of MACF was confirmed. The patient underwent laparoscopic unilateral salpingo-oophorectomy, with en bloc removal of the tumor. Her postoperative course was uneventful, and no recurrence was observed after over two years. This case underscores that high proliferative indices alone are insufficient for a fibrosarcoma diagnosis and highlights the safety and efficacy of minimally invasive, fertility-sparing surgery for MACF in young patients.<\/jats:p>","DOI":"10.3389\/fonc.2025.1680968","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:21:52Z","timestamp":1760502112000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic challenges and laparoscopic management of mitotically active cellular fibroma of the ovary: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Shuxu","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huangbei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13000-023-01406-9","article-title":"Bilateral ovarian fibromas as the sole manifestation of Gorlin syndrome in a 22-year-old woman: a case report and literature review","volume":"18","author":"Zhu","year":"2023","journal-title":"Diagn Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13048-020-00749-x","article-title":"Ovarian fibrosarcoma: A single-institution experience and a review of the literature","volume":"13","author":"Sun","year":"2020","journal-title":"J Ovarian Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"108938","DOI":"10.1016\/j.ijscr.2023.108938","article-title":"Ovarian fibrosarcoma: Diagnostic challenges and treatment options, a case report","volume":"112","author":"Mraihi","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200608000-00001","article-title":"Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma","volume":"30","author":"Irving","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/his.13977","article-title":"Revising the WHO classification: female genital tract tumours","volume":"76","author":"Cree","year":"2020","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0529-5807.2013.10.004","article-title":"Mitotically active cellular fibroma of ovary: a clinicopathologic analysis","volume":"42","author":"Bi","year":"2013","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2024.04.016","article-title":"Clinical, radiological, and pathological features of mitotically active cellular fibroma of ovary: A review of cases with literature review","volume":"63","author":"Kim","year":"2024","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11599","article-title":"Clinicopathological characteristics of mitotically-active cellular fibroma of the ovary: a single-institutional experience","volume":"37","author":"Kim","year":"2017","journal-title":"Anticancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000003059","article-title":"Ovarian mitotically active cellular fibroma of childhood: review of literature and report of a case","volume":"47","author":"Azari-Yam","year":"2025","journal-title":"J Pediatr Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000731","article-title":"Mitotically active cellular fibroma of the ovary recurring after the longest interval of time (16 yr): A challenging case with systematic literature review","volume":"40","author":"Olivadese","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13000-016-0554-7","article-title":"Rapid growth of mitotically active cellular fibroma of the ovary: a case report and review of the literature","volume":"11","author":"Matsuda","year":"2016","journal-title":"Diagn Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13048-015-0191-x","article-title":"Mitotically active cellular fibroma of the ovary: a case report and literature review","volume":"8","author":"Yamada","year":"2015","journal-title":"J Ovarian Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05082-3","article-title":"High Ki-67 expression is significantly associated with poor prognosis of ovarian cancer patients: evidence from a meta-analysis","volume":"299","author":"Qiu","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07888-2","article-title":"Predicting recurrence in adult granulosa cell tumors: the role of Ki67, p53, and TERT mutations","volume":"311","author":"Bayram","year":"2025","journal-title":"Arch Gynecol Obstet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1680968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:21:53Z","timestamp":1760502113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1680968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":14,"alternative-id":["10.3389\/fonc.2025.1680968"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1680968","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1680968"}}